Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$5.35 – $5.65
33% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $18.33B | $18.47B | $12.36B | $12.46B | $20.72B | $25.38B | $25.72B | $25.11B |
| Cost of revenue | $10.05B | $10.29B | $7.68B | $7.73B | $11.10B | $12.89B | $12.50B | $12.43B |
| Gross profit | $8.28B | $8.19B | $4.68B | $4.73B | $9.62B | $12.48B | $13.21B | $12.69B |
| Gross margin | 45.2% | 44.3% | 37.9% | 38.0% | 46.4% | 49.2% | 51.4% | 50.5% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $5.21B | $4.68B | $1.37B | $1.52B | $6.01B | $8.50B | $9.17B | $8.77B |
| EBITDA | $6.38B | $5.88B | $2.72B | $2.76B | $7.17B | $9.74B | $10.52B | $9.84B |
| Net income | $4.15B | $3.75B | $1.20B | $1.22B | $4.94B | $7.01B | $7.77B | $7.51B |
| Net margin | 22.7% | 20.3% | 9.7% | 9.8% | 23.8% | 27.6% | 30.2% | 29.9% |
| EPS (diluted) | 4.79 | 4.32 | 1.39 | 1.40 | 5.69 | 8.08 | 8.96 | 8.51 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $25.9B | $0.00 | $0.00–$0.00 | 0 |
| 2027 | $27.5B | $0.00 | $0.00–$0.00 | 0 |
Forward consensus · source: Financial Modeling Prep
BUMRUNGOLD HOSPITAL PCL
No one on the platform currently holds BUHPF.
No tracked institution reports a position in BUHPF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-03-18 | $3.0000 | 2026-05-12 |
| 2026-03-18 | $6.0000 | 2026-05-12 |
| 2025-08-15 | $2.0000 | 2025-09-29 |
| 2025-03-20 | $3.0000 | 2025-05-13 |
| 2024-08-26 | $2.0000 | 2024-09-06 |
| 2024-03-13 | $3.1500 | 2024-05-10 |
| 2023-08-24 | $1.3500 | 2023-09-06 |
No one on the platform has traded BUHPF yet.
| +0.00% |
| $6.1B |
| — |
| NHNKYNihon Kohden Corporation | $8.76 | -0.82% | $2.8B | — |
| RHCGFRyman Healthcare Limited | $1.08 | +0.00% | $1.1B | — |
Source: Financial Modeling Prep · peers by sector/industry
Trading at 0.6× earnings vs its 0.8× historical median P/E.
Fair value ≈ $6.89 · price $5.45 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.